Investors Overview
Why invest in LANXESS?
SALES Q1 2025
€ million
0
-0.4%
Q1 2024: 1,607 € million
EBITDA pre Q1 2025
€ million
0
+32%
Q1 2024: 101 € million
MARGIN Q1 2025
0
%
Q1 2024: 6.3%
UPCOMING EVENTS
INVESTORS NEWS
LANXESS – Energizing Chemistry!
LANXESS is a leading specialty chemicals company with sales of EUR 6.4 billion in 2024. The company currently has about 12,000 employees in 32 countries. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives and consumer protection products. LANXESS has achieved leading positions in the Dow Jones Best-in-Class Index and the MSCI ESG and ISS ESG ratings, among others, for its commitment to sustainability.